Skip to content
10-K

Annual Report

CONCENTRIX CORPORATION CNXC

0001803599-25-000022

← back to feed
Filed
Jan 28, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Jan 17, 2025 64.4M sh
Long Term Debt FY 2024 · Nov 30, 2023 $4.94B
Short Term Debt FY 2024 · Nov 30, 2023 $2.31M
Cash And Equivalents FY 2024 · Nov 30, 2023 $295.34M
Current Liabilities FY 2024 · Nov 30, 2023 $2.07B
Total Liabilities FY 2024 · Nov 30, 2023 $8.35B
Current Assets FY 2024 · Nov 30, 2023 $2.86B
Total Assets FY 2024 · Nov 30, 2023 $12.49B
Shares Diluted FY 2024 · Nov 30, 2022 51.74M sh
Stock Repurchased FY 2024 · Nov 30, 2022 $120.82M
Dividends Paid FY 2024 · Nov 30, 2022 $53.43M
Capex FY 2024 · Nov 30, 2022 $140.02M
Operating Cash Flow FY 2024 · Nov 30, 2022 $600.72M
Eps Diluted FY 2024 · Nov 30, 2022 $8.28
Eps Basic FY 2024 · Nov 30, 2022 $8.34
Sga Expense FY 2024 · Nov 30, 2022 $1.62B
Net Income FY 2024 · Nov 30, 2022 $435.05M
Operating Income FY 2024 · Nov 30, 2022 $640.19M
Gross Profit FY 2024 · Nov 30, 2022 $2.26B
Cost Of Revenue FY 2024 · Nov 30, 2022 $4.07B
Revenue FY 2024 · Nov 30, 2022 $6.32B
Stockholders Equity FY 2024 · Nov 30, 2021 $2.62B